Research programme: proteasome activator therapeutics - Booster Therapeutics
Alternative Names: proteasome activator therapeutics - Booster TherapeuticsLatest Information Update: 03 Dec 2024
Price :
$50 *
At a glance
- Originator Booster Therapeutics
- Developer Booster Therapeutics; Novo Holdings
- Class Small molecules
- Mechanism of Action Proteasome stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Neurodegenerative disorders